A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2018-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biopha.2018.02.119PMID 29501763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.

  2017cited by this paper
• DNA binding and Topoisomerase inhibition: How can these mechanisms be explored to design more specific anticancer agents?

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells

  2017cited by this paper
• Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer

  2016cited by this paper
• Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment

  2016cited by this paper
• 5-Acetyl goniothalamin suppresses proliferation of breast cancer cells via Wnt/β-catenin signaling.

  2016cited by this paper
• SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells

  2014cited by this paper
• Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition.

  2014cited by this paper
• Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analogues

  2013cited by this paper
• WNT signalling pathways as therapeutic targets in cancer

  2012cited by this paper
• New substituted C-19-andrographolide analogues with potent cytotoxic activities.

  2012cited by this paper
• Wnt/β-catenin signaling and disease.

  2012cited by this paper
• A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3β Protein-dependent Activation of the Wnt/β-Catenin Signaling Pathway*

  2012cited by this paper
• β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

  2012cited by this paper
• Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer

  2012cited by this paper
• Wnt signaling in cancer.

  2012cited by this paper
• Electrophilic natural products and their biological targets.

  2012cited by this paper
• All tangled up: how cells direct, manage and exploit topoisomerase function

  2011cited by this paper
• Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein.

  2011cited by this paper
• Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.

  2010cited by this paper
• Focus on histone variant H2AX: To be or not to be

  2010cited by this paper
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

  2009cited by this paper
• Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis

  2008cited by this paper
• Wnt signalling and its impact on development and cancer

  2008cited by this paper
• Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy

  2008cited by this paper
• Semisynthesis and in vitro anticancer activities of andrographolide analogues.

  2007cited by this paper
• Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.

  2007cited by this paper
• Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions

  2007cited by this paper
• Functional Interaction of DNA Topoisomerase IIα With the β-Catenin and T-Cell Factor-4 Complex

  2007cited by this paper
• Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.

  2004cited by this paper
• Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.

  2001cited by this paper
• Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human.

  2000cited by this paper
• The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

  1999cited by this paper
• The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

  1999cited by this paper
• Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways

  1999cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper

• Synthesis, antiproliferative activity, and biological profiling of C-19 trityl and silyl ether andrographolide analogs in colon cancer and breast cancer cells.

  2025cites this paper
• Exosomal microRNAs in cancer metastasis: A bridge between tumor micro and macroenvironment.

  2024cites this paper
• The role of silicon in drug discovery: a review

  2024cites this paper
• Role of natural products in tumor therapy from basic research and clinical perspectives

  2024cites this paper
• Andrographis paniculata and Andrographolide - A snapshot on Recent Advances in Nano Drug Delivery Systems Against Cancer.

  2023cites this paper
• Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis

  2022cites this paper
• Identification of potential andrographolide-based drug candidate against Keap1-Nrf2 pathway through rigorous cheminformatics screening

  2022cites this paper
• Tricyclic Aza-Andrographolide Derivatives from Late-Stage Hydroamination and Their Anti-human Coronavirus (Anti-HCoV) Activity

  2022cites this paper
• Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

  2022cites this paper
• Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.

  2022cites this paper
• Andrographolide suppresses breast cancer progression by modulating tumor‐associated macrophage polarization through the Wnt/β‐catenin pathway

  2022cites this paper
• Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β

  2022cites this paper
• Blocking the Wnt/β-catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)

  2022cites this paper
• Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective

  2021cites this paper
• A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.

  2021cites this paper
• The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer

  2021cites this paper
• Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis Against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells.

  2020cites this paper
• Gandou decoction, a Chinese medicinal formula, in the treatment of hepatic injury by Wnt/β-catenin pathway regulation in models of Wilson disease.

  2020cites this paper
• Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats.

  2020cites this paper
• The Prowess of Andrographolide as a Natural Weapon in the War against Cancer

  2020cites this paper
• Andrographolide: Synthetic Methods and Biological Activities.

  2020cites this paper
• Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents.

  2019cites this paper
• Fabrication and characterization of andrographolide analogue (3A.1) nanosuspensions stabilized by amphiphilic chitosan derivatives for colorectal cancer therapy

  2019cites this paper
• Apoptosis Induction and Antimigratory Activity of Andrographolide Analog (3A.1)-Incorporated Self-Assembled Nanoparticles in Cancer Cells

  2018cites this paper